Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06911398 · ClinicalTrials.gov registry record

AMIE's Clinical Conversational Abilities in an Urgent Care Setting

A clinical trial, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
100
Enrollment target

NCT06911398: Completed study, sponsored by Beth Israel Deaconess Medical Center.

NCT06911398 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06911398 has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

The purpose of this study is to determine the feasibility of a conversational artificial intelligence (AI) system to have a meaningful clinical conversation with a patient prior to an urgent care visit with their primary care physician. In this study, patients who are seeking an urgent care visit (that is, any type of medical visit with their primary care provider for a new complaint) will first have a conversation with an AI system. This interaction with the AI system will happen less than a week before their visit with their physician, and will be supervised by an independent physician who will interrupt in case there are any concerns about patient safety. After the interaction, a summary of the conversation will be sent to the patient's PCP, who will review prior to the in-person visit. The researchers will investigate: * Patient views on the AI system * PCP views on the AI system * Overall safety, as measured by the physician safety supervisor * Quality of clinical conversations, measured by standardized rubrics * Quality of diagnostic and management plans generated by the AI; these will not be shared with the patient or physician, but will be generated after the fact and compared with the actual diagnosis and management plan.

Primary Outcome

The researchers will collect the number of interruptions by the safety supervisor in response to safety concerns. There are four pre-specified interruption criteria; the researchers will connect the total number in each category, as well as a qualitative description of the type of error.

Interventions

  • OTHER Articulate Medical Intelligence Explorer (AMIE)

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-04-02
Est. Completion 2026-04-06

What the finished NCT06911398 record still lists

NCT06911398 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Articulate Medical Intelligence Explorer (AMIE) is the first listed.

NCT06911398 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06911398 about?

NCT06911398 is a clinical study titled "AMIE's Clinical Conversational Abilities in an Urgent Care Setting". The purpose of this study is to determine the feasibility of a conversational artificial intelligence (AI) system to have a meaningful clinical conversation with a patient prior to an urgent care visit with their primary care physician. In this study, patients who are seeking an urgent care visit (t...

What is the current status of trial NCT06911398?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2025-04-02. Estimated completion is 2026-04-06.

What interventions are being tested in trial NCT06911398?

The interventions under investigation include: Articulate Medical Intelligence Explorer (AMIE) (OTHER).

Who is sponsoring clinical trial NCT06911398?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06911398, the US trial registry maintained by the National Library of Medicine. NCT06911398 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.